Stocks to sell

The artificial intelligence bandwagon is getting fuller by the day, it seems. Even though it’s not a pure-play AI company by any means, meme-stock traders seem to be enamored with MicroCloud Hologram (NASDAQ:HOLO) lately. However, the risk greatly outweighs the rewards with HOLO stock unless you’re only in it for a quick trade. That’s what I

Rivian Automotive (NASDAQ:RIVN) stock has bounced back slightly in recent days but is more or less trading near all-time lows. Wall Street continues to give electric vehicle stocks the cold shoulder. Even as Rivian has been facing fewer issues than its competitors, most notably Lucid Group, remember that the market has soured even on profitable

Among electric vehicle makers, Rivian Automotive (NASDAQ:RIVN) is at the back of the pack. This will have important implications for RIVN stock holders. The company and its stock are in a rapidly deteriorating situation with no clear signs of recovery evident. Since last fall, Rivian Automotive has announced poor financial results, mounting losses, missed delivery

Recently, I watched portions of a YouTube video that tangentially but importantly related to overbought stocks to sell. An options trader boasted about an 80% success rate with his system, which sounded like nonsense. Come on, an 80% success rate? However, the trader revealed that he engages market opportunities with a short-term time horizon. Basically,

Even though the Fed’s interest rate hikes flushed a lot of losers out of the market since 2022, a handful of stocks to short remain, against all odds. These three companies are pure products of ZIRP-era enthusiasm, and though each trades well below pandemic period highs, they’re still grossly overvalued. While each may not face

While the current rally in equities looks to have legs, there are certain pockets of the market that are starting to get frothy. Stocks associated with artificial intelligence (AI) and cryptocurrencies have seen massive runs since the start of the year and look as though they could be in for a pullback if not a

This week, the Fed affirmed a “higher for longer” stance that could send some investors’ dreams tumbling down — particularly affecting these three stocks to sell. While each has had ups and downs over the past few years, the post-pandemic whiplash that included poor consumer sentiment and slacking sales may be the final nail in

Healthcare stocks, especially biotech companies, are very risky for investors. Their share price can be highly volatile and surge higher or plummet lower based on news regarding a clinical trial, treatment authorization, or any number of events that could be or break a company. In other industries, this massive shift in price action isn’t nearly

Crude oil prices have hovered between $75 and $85 a barrel since the start of this year, despite the ongoing conflict in the Middle East due to Israel’s war with Hamas. This has led to a continued slump in energy stocks, which have badly trailed the overall market for the better part of a year

Having gained almost 16,000% for early shareholders, there’s little doubt that electric vehicle manufacturer Tesla (NASDAQ:TSLA) ranks among the most groundbreaking enterprises in business history. At the same time, much of its success has been attributed to the company scooping up the low-hanging fruit. Now under a more mature market environment and with competitors moving

Identifying potential risks before they materialize into financial downturns is a must-have skill in the stock market. As the market shifts and companies face adversities, a vigilant eye on potential pitfalls is needed. Here is a dissection of the vulnerabilities of three prominent stocks. The first one, a retail giant, grapples with declining sales in

Throughout the history of financial markets, there is ample evidence of irrational investor behavior leading to euphoria. Be it the Tulip Mania of 1634 or the Housing Bubble and the subsequent financial crisis, markets tend to react on the extremes. Even today, I can spot quality stocks deeply undervalued and ignored. On the other hand,

As of this writing, Lucid Group (NASDAQ:LCID) trades for $3.33 per share. In other words, LCID stock, which came to be via a special purpose acquisition company merger, trades for around a third of the debut price of its SPAC predecessor. Comparing current prices to LCID’s all-time closing high ($58.05 per share), the gap is

So far this year, AI stocks are all the rage, and major indices like the S&P 500 are hitting new highs. However, things have been playing out differently in the world of penny stocks. This in turn highlights the need to know which penny stocks to sell. Although the market is a whole lot more

NIO (NYSE:NIO) stock doesn’t look great following recent earnings. The main reason is Nio’s lack of foresight to drive profitability and its abysmal market share in the Chinese EV market. Competition is heating up and the largest players are reducing prices to steal even more market share. We are already seeing the collapse of small

Stock markets have printed new record highs on the back of enthusiasm around artificial intelligence (AI), with the potential of uncovering overheated AI stocks to sell improving day by day. Of course, the resilience of the United States economy has contributed to the growth seen in certain AI stocks, like Nvidia. Moreover, expectations that the

With the broader indices such as the S&P 500 and the Nasdaq surging higher, there’s little sense for investors to hold on to these struggling stocks to sell. The potential for losses is very high with this list of companies, and I therefore advise investors to exercise caution. While it’s tempting to hold onto stocks

U.S. stocks sustained a jaw-breaking rally in 2023, with the Nasdaq beating all other indices, accruing a more than 43% return. While stocks largely did not begin 2024 with a great start, the major indices have risen in the past few weeks. Both major indices, S&P 500 and Nasdaq, have risen more than 7% year to date (YTD). While

Electric vehicles are one of the most exciting trends in the technology space. EVs hold the promise to deliver a great driving experience for consumers while helping the world hit key environmental goals. However, the growth of the EV market will not necessarily be a straight line upward. There are peaks and valleys along the

Much like Big Tech companies ride the AI hype, pharma stocks are counting on valuation boosts from big drug hits and FDA approvals. This anticipation, however, brings to light the importance of discerning which pharma stocks to sell, as not all will sustain their high-growth promises, potentially generating double-digit profits in the short term. This